The coronary artery bypass graft market is set for strong growth, driven by the rising prevalence of cardiovascular diseases, an aging population, and rapid advancements in surgical techniques. With a projected CAGR of 9.43% through 2034, innovations such as minimally invasive procedures, robotic-assisted surgeries, and improved graft materials are transforming cardiac treatment and improving patient outcomes worldwide.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Coronary Artery Bypass Graft Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Coronary Artery Bypass Graft Market Revenue and Volume, by Method
8.1.1 Off-pump
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. On-pump
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Minimally Invasive Direct
8.1.3.1. Market Revenue and Volume Forecast
9.1. Coronary Artery Bypass Graft Market Revenue and Volume, by Surgical Procedure
9.1.1. Single CABG Surgery
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Double CABG Surgery
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Triple CABG Surgery
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Quadruple CABG Surgery
9.1.4.1. Market Revenue and Volume Forecast
10.1. Coronary Artery Bypass Graft Market Revenue and Volume, by End use
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Cardiology Centers
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Method
11.1.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.1.3. Market Revenue and Volume Forecast, by End use
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Method
11.1.4.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.1.4.3. Market Revenue and Volume Forecast, by End use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Method
11.1.5.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.1.5.3. Market Revenue and Volume Forecast, by End use
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Method
11.2.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.2.3. Market Revenue and Volume Forecast, by End use
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Method
11.2.4.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.2.4.3. Market Revenue and Volume Forecast, by End use
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Method
11.2.5.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.2.5.3. Market Revenue and Volume Forecast, by End use
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Method
11.2.6.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.2.6.3. Market Revenue and Volume Forecast, by End use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Method
11.2.7.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.2.7.3. Market Revenue and Volume Forecast, by End use
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Method
11.3.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.3.3. Market Revenue and Volume Forecast, by End use
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Method
11.3.4.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.3.4.3. Market Revenue and Volume Forecast, by End use
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Method
11.3.5.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.3.5.3. Market Revenue and Volume Forecast, by End use
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Method
11.3.6.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.3.6.3. Market Revenue and Volume Forecast, by End use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Method
11.3.7.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.3.7.3. Market Revenue and Volume Forecast, by End use
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Method
11.4.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.4.3. Market Revenue and Volume Forecast, by End use
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Method
11.4.4.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.4.4.3. Market Revenue and Volume Forecast, by End use
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Method
11.4.5.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.4.5.3. Market Revenue and Volume Forecast, by End use
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Method
11.4.6.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.4.6.3. Market Revenue and Volume Forecast, by End use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Method
11.4.7.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.4.7.3. Market Revenue and Volume Forecast, by End use
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Method
11.5.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.5.3. Market Revenue and Volume Forecast, by End use
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Method
11.5.4.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.5.4.3. Market Revenue and Volume Forecast, by End use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Method
11.5.5.2. Market Revenue and Volume Forecast, by Surgical Procedure
11.5.5.3. Market Revenue and Volume Forecast, by End use
12.1. Edwards Lifesciences Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Getinge AB
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Genesee Biomedical
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Guidant Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. LivaNova plc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Medtronic plc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Novadaq Technologies Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Stryker Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description